| Nome |
# |
|
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c, file e1dcb333-f326-7715-e053-1705fe0a6cc9
|
105
|
|
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia, file e1dcb338-c510-7715-e053-1705fe0a6cc9
|
99
|
|
Non-invasive tests for the prediction of primary hepatocellular carcinoma, file e1dcb335-e3eb-7715-e053-1705fe0a6cc9
|
81
|
|
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study, file e1dcb331-c20c-7715-e053-1705fe0a6cc9
|
79
|
|
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome, file e1dcb331-afa2-7715-e053-1705fe0a6cc9
|
65
|
|
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation, file e1dcb337-1a1f-7715-e053-1705fe0a6cc9
|
63
|
|
null, file e1dcb333-2153-7715-e053-1705fe0a6cc9
|
61
|
|
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study, file e1dcb338-38aa-7715-e053-1705fe0a6cc9
|
47
|
|
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges, file e1dcb339-6fff-7715-e053-1705fe0a6cc9
|
36
|
|
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma, file e1dcb338-c1db-7715-e053-1705fe0a6cc9
|
33
|
|
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis, file 5a01e2cc-80a2-4718-bad6-292c231e8945
|
31
|
|
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation, file 767aa661-201f-461c-a669-35fd4f41cc2f
|
25
|
|
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study, file 15daacee-123d-42e5-8056-36f7ab28eb1e
|
23
|
|
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives, file aa4acf56-7736-4d8c-b794-73afbd170c0c
|
21
|
|
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness, file e1dcb338-7e57-7715-e053-1705fe0a6cc9
|
21
|
|
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis, file e1dcb337-ba8e-7715-e053-1705fe0a6cc9
|
19
|
|
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments, file e1dcb335-e240-7715-e053-1705fe0a6cc9
|
18
|
|
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease, file e4cfafa5-96d3-4cd3-9754-900cc4523dd7
|
18
|
|
Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease, file 1bcd85c2-c213-4246-a8f2-45fe4eb7c70e
|
17
|
|
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices, file e1dcb333-f0cc-7715-e053-1705fe0a6cc9
|
17
|
|
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years, file e1dcb338-a11f-7715-e053-1705fe0a6cc9
|
17
|
|
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease, file 4afc7f87-e2a1-4ee1-8ed5-13765939e29e
|
12
|
|
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond, file e1dcb331-52b1-7715-e053-1705fe0a6cc9
|
12
|
|
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests, file e1dcb331-9328-7715-e053-1705fe0a6cc9
|
10
|
|
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice, file e1dcb338-a3d8-7715-e053-1705fe0a6cc9
|
10
|
|
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals, file e1dcb332-82ab-7715-e053-1705fe0a6cc9
|
8
|
|
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis, file 6fcca37f-3c6c-4dda-873c-ab652592729a
|
7
|
|
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens, file e1dcb32f-dada-7715-e053-1705fe0a6cc9
|
7
|
|
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients, file e1dcb330-1558-7715-e053-1705fe0a6cc9
|
7
|
|
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients, file e1dcb330-1c0b-7715-e053-1705fe0a6cc9
|
7
|
|
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection, file e1dcb331-2ae6-7715-e053-1705fe0a6cc9
|
7
|
|
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly, file e1dcb335-d93e-7715-e053-1705fe0a6cc9
|
7
|
|
Clinical outcomes after treatment with direct-acting antivirals: not all concern hepatocellular carcinoma risk, file 2167dfb9-e745-44b7-9874-16be17faeaf9
|
6
|
|
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients, file d2b192e3-d31f-4e67-b2c8-a9aa8940d38e
|
6
|
|
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis, file bd0dadf8-be0b-453e-a1f8-92403a890824
|
5
|
|
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma, file 473dc475-b8ca-4079-a115-c4d2dc3af6d9
|
4
|
|
THU-086 - The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients, file e1dcb32f-d638-7715-e053-1705fe0a6cc9
|
4
|
|
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods, file e1dcb330-22e9-7715-e053-1705fe0a6cc9
|
4
|
|
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs, file 4a6919ef-7e88-4d9a-9a1e-646cc39746e8
|
3
|
|
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia, file 6b91808a-89ec-451f-bcac-4bd100943c74
|
3
|
|
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease, file add76849-23a4-42bf-ba74-4f3bf0a03e77
|
3
|
|
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients, file e1dcb332-1b02-7715-e053-1705fe0a6cc9
|
3
|
|
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study, file e1dcb339-f327-7715-e053-1705fe0a6cc9
|
3
|
|
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients, file 1b10dee3-f570-4514-9abe-0b415b53281f
|
2
|
|
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study, file 21d6cb53-9aff-44d9-8f81-02dfbbe12e81
|
2
|
|
Comparison of screening strategies with two new tests to score and diagnose varices needing treatment, file 4dd67669-e6a5-41d0-b180-cdbdc0a7e846
|
2
|
|
Sound Conclusions: How Splenic Elastography May Decrease the Need for Endoscopic Variceal Surveillance, file e1dcb333-2ed7-7715-e053-1705fe0a6cc9
|
2
|
|
Predictive factors for hepatocellular carcinoma recurrence after curative treatments, file e1dcb335-d940-7715-e053-1705fe0a6cc9
|
2
|
|
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients, file e1dcb336-0b8e-7715-e053-1705fe0a6cc9
|
2
|
|
The changing scenario of hepatocellular carcinoma in Italy: an update, file 018f1cec-a209-41c4-ab00-402e5158d9b0
|
1
|
|
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival, file 06c302eb-3b45-4b6a-a7c7-3465d2b981fd
|
1
|
|
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis, file 2718c244-84a6-49ac-8fb4-aba1afa9b547
|
1
|
|
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm, file 45487a3c-dacf-4329-af0a-54c0da74922d
|
1
|
|
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation, file 8f37343e-e4e5-4392-883d-2f322241f619
|
1
|
|
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis, file 94889736-85b2-4d7b-88fb-2e7e8a413800
|
1
|
|
Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis, file 9ecd713e-1a09-4d93-99ca-7af2566a8685
|
1
|
|
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness, file b8e93c7f-79e7-4dd4-ad79-63febe61a931
|
1
|
|
null, file e1dcb331-2ae8-7715-e053-1705fe0a6cc9
|
1
|
|
Prediction of posthepatectomy liver failure: Role of SSM and LSPS, file e1dcb331-932a-7715-e053-1705fe0a6cc9
|
1
|
|
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study, file e1dcb336-72ff-7715-e053-1705fe0a6cc9
|
1
|
|
Comparison of screening strategies with two new tests to score and diagnose varices needing treatment, file e323a021-7de3-483e-b799-2f429b316789
|
1
|
| Totale |
1.058 |